Calnexin is a calcium-binding protein embedded in the ER membrane that retains the newly synthesized glycoproteins inside the ER to ensure proper folding and quality control (3-5). The specificity of calnexin for a subset of glycoproteins is defined by a lectin site, which binds an early oligosaccharide intermediate on the folding glycoprotein.

 

產(chǎn)品性質(zhì)

別名	CANX; Calnexin; IP90; Major histocompatibility complex class I antigen-binding protein p88; p90
SwissProt ID	P27824
基因ID	821
免疫原	The antiserum was produced against synthesized peptide derived from human Calnexin.
緩沖液	Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.
分子量	Calculated MW: 68 kDa; Observed MW: 90 kDa
克隆類(lèi)型	Polyclonal Antibody
宿主	Rabbit
物種反應(yīng)	Human, Mouse, Rat
推薦應(yīng)用	WB, IHC-F, IHC-P, ICC/IF, ELISA
純化方式	Affinity Purified

 

應(yīng)用

稀釋比 WB:1/500-1/1000; IHC:1/50-1/100；IF:1/50-1/200; ELISA: 1/10000

 

儲(chǔ)存條件

-25~-15℃保存

 

注意事項(xiàng)

1. 避免反復(fù)凍融。

2. 本產(chǎn)品僅作科研用途。

3. 為了您的安全和健康，請(qǐng)穿實(shí)驗(yàn)服并佩戴一次性手套操作。

 

產(chǎn)品數(shù)據(jù)

Western blot

Western blot analysis of Calnexin in CHO-K1, Jurkat, 3T3, C6 and HeLa lysates using Calnexin antibody.

 

Ver.CN20231010